These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24289101)

  • 1. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.
    François A; Chatelus E; Wachsmann D; Sibilia J; Bahram S; Alsaleh G; Gottenberg JE
    Arthritis Res Ther; 2013 Oct; 15(5):R168. PubMed ID: 24289101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
    Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
    Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of the transforming growth factor β-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target.
    Piera-Velazquez S; Fertala J; Huaman-Vargas G; Louneva N; Jiménez SA
    Rheumatology (Oxford); 2020 Oct; 59(10):3092-3098. PubMed ID: 32442272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis.
    Arvia R; Margheri F; Stincarelli MA; Laurenzana A; Fibbi G; Gallinella G; Ferri C; Del Rosso M; Zakrzewska K
    Rheumatology (Oxford); 2020 Nov; 59(11):3526-3532. PubMed ID: 32556240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profibrotic Activation of Human Macrophages in Systemic Sclerosis.
    Bhandari R; Ball MS; Martyanov V; Popovich D; Schaafsma E; Han S; ElTanbouly M; Orzechowski NM; Carns M; Arroyo E; Aren K; Hinchcliff M; Whitfield ML; Pioli PA
    Arthritis Rheumatol; 2020 Jul; 72(7):1160-1169. PubMed ID: 32134204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients.
    Lapoirie J; Tran L; Piazza L; Contin-Bordes C; Truchetet ME; Bonnet F
    Sci Rep; 2021 Sep; 11(1):18011. PubMed ID: 34504265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities.
    Peng B; Hu Q; He R; Hou H; Lian D; Chen Y; Li H; Song L; Gao Y; Chen T; Zhang G; Li J
    BMC Complement Med Ther; 2023 Feb; 23(1):62. PubMed ID: 36810081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
    Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
    Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
    Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
    Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
    Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
    Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acids exhibit anti-fibrotic activity through the inhibition of 5-lipoxygenase expression in scleroderma fibroblasts.
    Xiao R; Yoshida N; Higashi Y; Lu QJ; Fukushige T; Kanzaki T; Kanekura T
    J Dermatol; 2011 Apr; 38(4):345-53. PubMed ID: 21352343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.
    Agarwal SK; Wu M; Livingston CK; Parks DH; Mayes MD; Arnett FC; Tan FK
    Arthritis Res Ther; 2011 Jan; 13(1):R3. PubMed ID: 21223583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.
    Dufour AM; Alvarez M; Russo B; Chizzolini C
    Front Immunol; 2018; 9():1865. PubMed ID: 30150989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
    Brown Lobbins ML; Shivakumar BR; Postlethwaite AE; Hasty KA
    Clin Exp Immunol; 2018 Jan; 191(1):84-95. PubMed ID: 28884475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
    Raschi E; Privitera D; Bodio C; Lonati PA; Borghi MO; Ingegnoli F; Meroni PL; Chighizola CB
    Arthritis Res Ther; 2020 Nov; 22(1):265. PubMed ID: 33168071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.